DLBCL
Clinical trials for DLBCL explained in plain language.
Never miss a new study
Get alerted when new DLBCL trials appear
Sign up with your email to follow new studies for DLBCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lymphoma patients: experimental drug combo enters human trials
Disease control Not yet recruitingThis early-phase study tests a new drug (rocbrutinib) combined with standard chemotherapy for people with a type of blood cancer (diffuse large B-cell lymphoma) that has come back or not responded to prior treatment. The main goal is to find a safe dose and check for side effects…
Matched conditions: DLBCL
Phase: PHASE1 • Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. • Aim: Disease control
Last updated May 17, 2026 05:24 UTC
-
New 'Living Drug' trial targets Tough-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy, called BAFF-R CAR-T, for people with B-cell lymphomas that have come back or haven't responded to other treatments. Researchers will give the therapy at different doses to about 20 participants to check how safe …
Matched conditions: DLBCL
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 06, 2026 14:05 UTC
-
Gut bugs may predict lymphoma drug success
Knowledge-focused Not yet recruitingThis study looks at how the bacteria in your gut might influence how well a drug called glofitamab works against a type of lymphoma (DLBCL). Researchers will collect stool samples from 30 patients before, during, and up to one year after treatment to see if certain gut bacteria a…
Matched conditions: DLBCL
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC